Status:
COMPLETED
Muscle Strength Exercise and Sleep Apnea
Lead Sponsor:
Turku University Hospital
Collaborating Sponsors:
WellO2 Oy
University of Turku
Conditions:
Sleep Apnea
Eligibility:
All Genders
18-60 years
Phase:
NA
Brief Summary
Background: Obstructive sleep apnea is one of our common diseases and up to 80% of patients are estimated to be undiagnosed. Its main risk factors are overweight, age, male gender, menopause, small j...
Detailed Description
Research objectives: 1. Will AHI change after 3 months of use of WellO2 (PSG in the beginning and after 3 months) 2. Will the participants get help with fatigue symptoms or quality of life (questionn...
Eligibility Criteria
Inclusion
- Age 18-60 years
- Male:Famel 1:1
- AHI 10-29 / h
- working patients
Exclusion
- Previous surgical treatment for sleep apnea, current CPAP or mandibular device therapy
- significant history of nasal, oral and pharyngeal disorders
- BMI\> 40 kg / m2
- other severe pulmonary diseases (eg COPD, asthma, pulmonary fibrosis) severe heart failure (NYHA 3-4), previous brain insult, neuromuscular disease or pregnancy, and work disability.
Key Trial Info
Start Date :
May 23 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 31 2024
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT05320952
Start Date
May 23 2022
End Date
August 31 2024
Last Update
May 31 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Turku University Hospital, Division of Medicine, Dept of Pulmonary diseases and University of Turku, Sleep Research Centre
Turku, Finland, 20520